Add To Watchlist
Share URL
About The Company
CEO
Mr. Ashish Ramdas Nayak
Market Cap
20.03 Billion INR
Sector
Healthcare
Website
https://www.supriyalifescience.comDescription
Supriya Lifescience Ltd.
Read More
Overview
Value
28
Growth
69
Health
48
Management
61
Analyst Opinion
0
Total
52
All Scores Out Of 100
Best Features
- Very strong cashflow and earnings growth
- Has a low level of debt
- Price-to-earnings ratio of 10.3 is lower than the market average (19.6x)
- Has strong dividend growth
- Low preportion of income is paid as dividend
Risk Factors
- Earnings have declined recently
- No margin of safety at their current market price
Market Peers
SUPRIYA.NS
Key Figures
PE Ratio (TTM)
10.28
Margin Of Safety (DCF)
-38.79%
Revenue Growth (5 Year Average)
18.12%
Ratings Consensus
N/A
Share Buybacks
N/A
Dividend Yeild (TTM)
N/A
Valuation
Value Score
28
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 231.6 INR ✘
Current Price: 251.9 INR
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
10.28x
Free Cashflow Yeild
N/A
PE/Earnings Growth
0.45
Price/Book
3.11x
Growth
Growth Score
69
- ✔ 5 Year Average Revenue growth of 18.12% is higher than the market average (10.97%)
- ✔ Revenue growth has improved this yeara
- ✔ 5 Year Average Earnings growth of 24.55% is higher than the market average (14.48%)
- ✔ 5 Year Average Cashflow growth of 12.36% is higher than the market average (12.35%)
- ✘ Earnings growth has slowed this year
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
18.12%
Earnings Growth
24.55%
Cashflow Growth
12.36%
Health
Health Score
48
Altman Z Score
N/A
Piostroski Score
N/A
Debt/Equity
0.04x
Current Assets/Liabilities
4.99x
Free Cashflow/Total Debt
N/Ax
Debt/Capital
0.06x
Dividend
Secure Dividend Score
38
- ✘ At risk of being unsafe
- ✔ Long term dividend payout ratio of 7.53% is considered good
- ✔ Payout ratio (TTM) of N/A is lower than the average (40%)
- ✔ Dividends have shown growth over the last 5 years
- ✔ Dividend growth has been accelerating recently
- ✔ Spending a lower percentage of their income on dividends than last 5 years
- ✘ Dividend yeild of N/A is less than the market average (1.85%)
Dividend Yeild
N/A
Dividend Growth
11.00%
Payout Ratio (Earnings)
N/A
Payout Ratio (Cashflow)
N/A
Management
Management Score
61
Average Buybacks/Dilution
N/A
Recent Buybacks/Dilution
N/A
5 Year Price Volitility
22.25%
Return On Assets
65.09%
Return On Capital Employed
27.76%
Return On Equity
77.68%
Return On Free Cashflow
1509.20%
Return On Investments
902360.58%
Analysts
Analyst Opinion
0
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Supriya Lifescience Limited
Currency
INR
Beta
0
Vol Avg
194380
Ceo
Mr. Ashish Ramdas Nayak
Cik
Cusip
Exchange
National Stock Exchange of India
Full Time Employees
356
Industry
Biotechnology
Sector
Healthcare
Ipo Date
2021-12-28
Address
207/208 Udyog Bhavan
City
Mumbai
State
Country
IN
Zip
400063
Phone
91 22 4033 2727
All financial data provided by FMP